Product Information
VICTOZA 2-PAK 18 MG/3 ML PEN is a brand product labeled by Novo Nordisk, priced at $87.7313 per ML under NDC 00169406012. Its NADAC has been published 647 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the liraglutide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/mL
Manufacturer
Novo NordiskNDC
00169406012
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
LIRAGLUTIDEApproval Type
New Drug (NDA)
FDA Application
NDA022341On Market Since
1/25/2010
Pharmacological Classes
Price Statistics
The NADAC for VICTOZA 2-PAK 18 MG/3 ML PEN has been published 647 times since Nov 28, 2013, and over the history we have for it it has risen 65.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $87.7313 per ML |
|---|---|
| All-time high | $119.6468 (Jan 3, 2024) |
| All-time low | $53.0874 (Nov 28, 2013) |
| 52-week high | $87.8946 |
| 52-week low | $87.4917 |
| Median price | $87.5306 |
| Average price | $91.3736 |
| Largest weekly change | -27.0% (Jan 10, 2024) |
| Weeks tracked | 647 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VICTOZA 2-PAK 18 MG/3 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for VICTOZA 2-PAK 18 MG/3 ML PEN, manufactured by Novo Nordisk, is $87.7313 per ML (NDC 00169406012), effective Jun 24, 2026.
How has the price of VICTOZA 2-PAK 18 MG/3 ML PEN changed over time?
Over the history we have for it, the NADAC for VICTOZA 2-PAK 18 MG/3 ML PEN has risen 65.3%. It has been tracked across 647 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VICTOZA 2-PAK 18 MG/3 ML PEN?
Since Nov 28, 2013, the NADAC for VICTOZA 2-PAK 18 MG/3 ML PEN has ranged from a low of $53.0874 (Nov 28, 2013) to a high of $119.6468 (Jan 3, 2024), with a median of $87.5306 per ML.
Are there cheaper alternatives to VICTOZA 2-PAK 18 MG/3 ML PEN?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $33.4153 per ML — about 62% below VICTOZA 2-PAK 18 MG/3 ML PEN.
Who manufactures VICTOZA 2-PAK 18 MG/3 ML PEN?
VICTOZA 2-PAK 18 MG/3 ML PEN (NDC 00169406012) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification